Welcome to the home page of Pål André Holme's research group
Platelet and coagulation: clinical and basic research
Group leader Pål André Holme, MD, PhD
Engineer Stine Bjørnsen
Associated Researcher Pål Andre Holme, MD, PhD
Professor Geir E. Tjønnfjord, MD, PhD
PhD student Hoa Thi Tuyet Tran, MD
About our research
Platelet and coagulation: clinical and basic research
Our scientific interests are focused on clinical and basic aspects of normal and disturbed haemostasis.
The clinical part is concerned with diagnosis and treatment of disturbances of the thrombohaemorrhagic balance as seen in:
- Glanzmann’s thrombasthenia and in the Bernard-Soulier Syndrome
- Storage Pool Disease
- Sticky Platelet Syndrome
- Drug-dependent platelet hyper/hypo-aggregability
- Hereditary and acquired coagulation factor deficiencies with special emphasis on development of inhibitors and management
The basic part of our research concerns platelet metabolic and morphologic changes caused by activation by physiological agonist; i.e. microparticle formation, secretion of chemokines/interleukins, interaction with endothelium and monocytes, initiation and support of coagulation factor activation, intraplatelet protein synthesis.
Tools and methods used in the above mentioned research are those common to all advanced cell biology, enzymology and protein chemistry.
Latest publications
Pål André Holme
Continuous infusion in haemophilia: current practice in Europe
Haemophilia, 18 (5), 753-9
PubMed 22530687
Combined treatment with APCC (FEIBA®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A--a two-centre experience
Haemophilia, 18 (4), 544-9
PubMed 22348384
Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial
Lancet, 379 (9810), 31-8
PubMed 22172244





Print this page
